YOLFTbeta
00

Jinhe Biotechnology Co Ltd

002688 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

4.55CNY-0.02 (-0.44%)

Price History

Full chart

Market Stats

Previous Close4.57
Open4.57
Day Range4.53 – 4.63
52-Week Range4.58 – 7.11
Volume6.06M
Market Cap4.33B
P/E (TTM)172.33
Forward P/E0.00
EPS0.03
Dividend Yield1.95%
Beta0.33
50-Day Avg5.18
200-Day Avg5.66

About

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of pet food; sales of food additives; and raw materials. In addition, the company provides chlortetracycline, oxytetracycline, and other formulations. The company was founded in 1990 and is headquartered in Hohhot, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Changxian Xie
  • Employees2.71K
  • HeadquartersNo. 71, Xinping Road, Hohhot, China, 010200, China
  • Websitehttps://www.jinhe.com.cn

Leadership

  • Mr. Changxian XieGM & Director · b. 1962
  • Mr. You Shan NiuFinancial Director · b. 1971
  • Mr. Zhi Jun WangDeputy GM & Director · b. 1974
  • Mr. Manman LuAssistant to Chairman of Board, Board Secretary & Director · b. 1973
  • Mr. Ying Chun LiuDeputy General Manager · b. 1967
  • Mr. Yingzhen GuanDeputy General Manager · b. 1964
  • Mr. Xibao YunDeputy General Manager · b. 1967
  • Mr. Cheng Min GuoDeputy General Manager · b. 1984
  • Lihang ZhouChief Accounting Officer
  • Mr. Mingsheng JianDeputy General Manager · b. 1966

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue444.39M458.75M590.22M720.73M770.41M741.07M839.81M1.25B1.50B1.46B1.63B1.78B1.81B2.08B2.12B2.17B2.37B2.88B
Growth (%)-+3.23%+28.66%+22.11%+6.89%-3.81%+13.32%+48.90%+19.61%-2.53%+11.73%+9.42%+1.81%+14.51%+2.15%+2.42%+9.04%+21.41%
Cost of Revenue346.49M340.26M404.62M478.77M534.82M496.35M604.28M904.63M1.01B922.66M1.04B1.16B1.22B1.47B1.55B1.57B1.64B1.90B
Gross Profit97.89M118.49M185.60M241.96M235.58M244.72M235.52M345.84M484.70M535.16M591.14M623.42M598.34M605.66M577.47M602.51M729.97M974.50M
Gross Margin22.03%25.83%31.45%33.57%30.58%33.02%28.04%27.66%32.41%36.71%36.29%34.98%32.97%29.15%27.20%27.71%30.79%33.86%
Operating Expense79.40M86.75M124.06M154.62M124.55M137.95M152.11M224.92M275.49M387.52M393.66M447.40M468.91M465.95M456.23M497.78M631.41M636.54M
Operating Income18.49M31.74M61.54M87.33M111.03M106.78M83.41M120.92M209.21M147.65M197.48M176.02M129.43M139.71M121.24M104.73M98.55M337.96M
Operating Margin4.16%6.92%10.43%12.12%14.41%14.41%9.93%9.67%13.99%10.13%12.12%9.88%7.13%6.72%5.71%4.82%4.16%11.74%
EBITDA38.88M77.19M114.19M145.74M160.71M148.23M139.28M210.33M298.02M259.71M333.70M383.81M323.69M327.73M307.35M334.54M276.99M364.19M
EBITDA Margin8.75%16.83%19.35%20.22%20.86%20.00%16.58%16.82%19.93%17.81%20.49%21.53%17.84%15.77%14.48%15.39%11.68%12.65%
Net Income15.87M27.03M52.75M77.40M89.58M90.43M77.21M104.65M164.13M108.42M163.63M184.94M117.32M93.99M75.62M86.46M100.20M27.56M
Net Income Margin3.57%5.89%8.94%10.74%11.63%12.20%9.19%8.37%10.97%7.44%10.05%10.38%6.47%4.52%3.56%3.98%4.23%0.96%
R&D-706.46K1.01M931.43K5.64M5.78M4.20M23.52M11.31M33.53M40.51M60.70M66.36M72.25M82.28M74.00M114.43M116.55M
R&D as % of Total Revenue-0.15%0.17%0.13%0.73%0.78%0.50%1.88%0.76%2.30%2.49%3.41%3.66%3.48%3.88%3.40%4.83%4.05%
Interest Expense19.67M14.21M15.57M15.89M14.27M2.96M3.14M27.68M26.67M39.92M52.86M64.16M62.83M53.85M39.32M60.17M5.98M86.11M
Interest Expense % of Total Revenue4.43%3.10%2.64%2.20%1.85%0.40%0.37%2.21%1.78%2.74%3.24%3.60%3.46%2.59%1.85%2.77%0.25%2.99%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets566.45M618.59M623.92M670.84M1.00B1.02B1.52B1.89B2.66B2.96B3.34B3.34B3.38B4.06B4.51B5.45B5.65B5.52B
Total Liabilities388.63M422.56M369.09M336.44M139.83M116.81M562.50M830.68M1.08B1.32B1.56B1.54B1.63B1.37B2.08B2.94B3.15B3.08B
Total Equity165.98M184.84M242.29M322.50M864.40M900.58M950.58M1.04B1.50B1.53B1.68B1.68B1.61B2.44B2.22B2.25B2.25B2.23B
Cash71.79M77.44M61.35M87.84M373.46M275.22M228.78M225.42M239.38M345.29M491.81M361.91M314.80M517.66M491.37M608.13M635.89M618.35M
Total Debt256.40M283.90M280.00M255.50M60.00M30.00M417.14M618.56M523.77M891.05M1.19B1.20B1.33B1.01B1.60B2.21B2.02B-
Net Debt184.61M206.46M218.65M167.66M-313.46M-245.22M188.36M393.14M284.39M545.76M700.33M834.20M1.02B490.44M1.11B1.60B1.38B1.10B

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow11.64M23.20M118.05M106.59M88.81M148.32M-58.02M214.97M292.41M27.25M117.17M282.19M258.08M152.98M124.47M198.77M498.42M468.92M
Investing Cash Flow-27.50M-23.00M-54.87M-39.50M-51.54M-160.14M-347.38M-371.03M-456.17M-284.92M-192.02M-184.08M-204.41M-397.99M-386.80M-537.94M-371.46M-
Financing Cash Flow82.97M5.45M-79.24M-40.55M248.37M-86.41M278.89M196.13M207.10M253.98M153.57M-185.94M27.60M448.70M150.43M413.05M-39.89M-
Capital Expenditure27.50M23.00M54.80M39.43M34.50M160.55M348.52M142.08M128.57M196.57M170.18M178.85M204.01M383.72M402.16M457.22M362.24M320.28M
Free Cash Flow-15.86M193.05K63.25M67.16M54.30M-12.23M-406.54M72.88M163.85M-169.31M-53.00M103.34M54.07M-230.74M-277.69M-258.45M136.18M148.64M
Dividends Paid15.96M22.38M15.57M16.27M14.56M56.47M31.90M40.42M98.77M141.70M65.14M158.82M158.82M63.53M40.55M148.69M160.96M147.85M
FCF to OCF-136.31%0.83%53.58%63.01%61.15%-8.24%700.73%33.90%56.03%-621.27%-45.24%36.62%20.95%-150.83%-223.09%-130.03%27.32%31.70%
Dividend Paid to FCF-100.61%11591.70%24.62%24.23%26.82%-461.82%-7.85%55.46%60.28%-83.69%-122.90%153.69%293.72%-27.53%-14.60%-57.53%118.19%99.46%

Earnings

Report DateSep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Feb 27, 2016Apr 24, 2016Aug 16, 2016Oct 25, 2016Apr 25, 2017Aug 24, 2017Oct 19, 2017Feb 27, 2018Apr 23, 2018Aug 15, 2018Oct 21, 2018Mar 28, 2019Apr 23, 2019Aug 23, 2019Oct 22, 2019Apr 22, 2020Aug 23, 2020Oct 26, 2020Apr 20, 2021Aug 23, 2021Oct 25, 2021Mar 25, 2022Apr 21, 2022Aug 12, 2022Oct 31, 2022Apr 21, 2023Aug 22, 2023Oct 29, 2023Apr 28, 2024Aug 29, 2024Oct 27, 2024Mar 27, 2025Apr 25, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------
EPS Actual0.020.060.030.050.040.050.040.050.020.030.040.050.030.070.080.070.050.060.060.040.010.050.090.070.050.060.110.060.090.060.010.020.050.01-0.02-0.040.070.02-0.040.070.020.060.060.03-0.020.070.120.00-0.150.080.09
Surprise---------------------------------------------------
Timing-------------After-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours-After-hours--Pre-marketPre-marketAfter-hoursPre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap4.33B
Enterprise Value5.99B
Trailing P/E172.33
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.47
Price / Book1.91
EPS0.03
Book Value3.01
Revenue (TTM)2.94B
Gross Profit (TTM)992.09M
EBITDA553.72M
Profit Margin0.70%
Operating Margin16.73%
Return on Equity-0.54%
Return on Assets3.44%
Shares Outstanding837.38M
Shares Float478.72M
Beta0.33
Dividend Yield1.95%
Dividend Rate0.10
Payout Ratio3.62%

Dividends

20261×
0.10Jun 1, 2026
20251×
0.10Jun 6, 2025
20241×
0.10May 31, 2024
20231×
0.10Jun 5, 2023
20211×
0.10Apr 30, 2021
20201×
0.25May 21, 2020
20191×
0.25Apr 30, 2019
20181×
0.03May 17, 2018
20171×
0.15May 18, 2017
20161×
0.08May 17, 2016
20151×
0.04May 22, 2015
20141×
0.10May 13, 2014
20131×
0.10Apr 12, 2013

Stock Splits

  • May 17, 201625:10
  • May 13, 201420:10